(株)ケイファーマの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4896/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/04/19 | 日証協 | 217,300株 | -6.86% | 54,600株 | +658.33% | 218,967株 | -1.71% | 6,201株 | +81.53% |
2024/04/12 | 日証協 | 233,300株 | -1.73% | 7,200株 | +278.95% | 222,766株 | +0.64% | 3,416株 | -14.6% |
2024/04/05 | 日証協 | 237,400株 | -2.59% | 1,900株 | -90.31% | 221,350株 | -1.38% | 4,000株 | -63.64% |
2024/03/29 | 日証協 | 243,700株 | -4.02% | 19,600株 | +145% | 224,450株 | -4.43% | 11,000株 | +233.33% |
2024/03/22 | 日証協 | 253,900株 | -0.98% | 8,000株 | -92.17% | 234,850株 | +0.9% | 3,300株 | -88.96% |
2024/03/15 | 日証協 | 256,400株 | +3.97% | 102,200株 | +1177.5% | 232,750株 | +2.65% | 29,900株 | +218.05% |
2024/03/08 | 日証協 | 246,600株 | +2.15% | 8,000株 | -95.46% | 226,749株 | +2.49% | 9,401株 | -40.12% |
2024/03/01 | 日証協 | 241,400株 | +8.45% | 176,100株 | +158.59% | 221,249株 | +4.74% | 15,700株 | +551.99% |
2024/02/22 | 日証協 | 222,600株 | -3.72% | 68,100株 | +130.85% | 211,241株 | -1.35% | 2,408株 | -80.89% |
2024/02/16 | 日証協 | 231,200株 | -11.65% | 29,500株 | +21.9% | 214,141株 | -6.91% | 12,600株 | +53.66% |
2024/02/09 | 日証協 | 261,700株 | +2.67% | 24,200株 | +11.01% | 230,041株 | +1.01% | 8,200株 | -41.43% |
2024/02/02 | 日証協 | 254,900株 | -10.91% | 21,800株 | -79.66% | 227,741株 | -5.91% | 14,000株 | +26.13% |
2024/01/26 | 日証協 | 286,100株 | -3.34% | 107,200株 | -54.75% | 242,041株 | +5.08% | 11,100株 | -78.49% |
2024/01/19 | 日証協 | 296,000株 | +17.79% | 236,900株 | +11.43% | 230,341株 | +9.72% | 51,600株 | -46.76% |
2024/01/12 | 日証協 | 251,300株 | +96.02% | 212,600株 | +3274.6% | 209,933株 | +41.63% | 96,916株 | +988.94% |
2024/01/05 | 日証協 | 128,200株 | -5.53% | 6,300株 | -51.16% | 148,225株 | -7.79% | 8,900株 | -39.04% |
2023/12/29 | 日証協 | 135,700株 | -32.52% | 12,900株 | +214.63% | 160,742株 | -23.36% | 14,600株 | +43.07% |
2023/12/22 | 日証協 | 201,100株 | -18.81% | 4,100株 | -80.38% | 209,737株 | -8.46% | 10,205株 | -28.18% |
2023/12/15 | 日証協 | 247,700株 | +6.13% | 20,900株 | -72.5% | 229,128株 | +5.33% | 14,209株 | -76.86% |
※株式分割は考慮していませんのでご注意ください。
Page Top